ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia

被引:74
作者
Broome, H. Elizabeth [1 ]
Rassenti, Laura Z. [2 ]
Wang, Huan-You [1 ]
Meyer, Lilly M. [1 ]
Kipps, Thomas J. [2 ]
机构
[1] Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, Moores Canc Ctr, La Jolla, CA 92093 USA
关键词
ROR1; Wnt; B-lymphocyte precursors; Hematogones; Acute lymphoblastic leukemia; t(1; 19); Chronic lymphocytic leukemia; Flow cytometry; RECEPTOR TYROSINE KINASE; BONE-MARROW; CELL PRECURSORS; TARGET;
D O I
10.1016/j.leukres.2011.06.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
ROR1 is a receptor tyrosine kinase expressed during embryogenesis, on chronic lymphocytic leukemia (CLL) and in other malignancies. Hematogones (non-neoplastic B-lymphocyte precursors) express surface ROR1 at an intermediate stage of maturation that lacks CD34 or TdT. The neoplastic counterpart to hematogones is precursor-B acute lymphoblastic leukemia (B-ALL), but less than 10% of B-ALL express surface ROR1, and these ROR1+ B-ALL cases have an unusually high frequency of lacking CD34 and/or having t(1; 19), a chromosomal translocation that defines a specific subtype of B-ALL. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1390 / 1394
页数:5
相关论文
共 15 条
[1]
Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia [J].
Baskar, Sivasubramanian ;
Kwong, Kayin ;
Hofer, Thomas ;
Levy, Jessica M. ;
Kennedy, Michael G. ;
Lee, Elinor ;
Staudt, Louis M. ;
Wilson, Wyndham H. ;
Wiestner, Adrian ;
Rader, Christoph .
CLINICAL CANCER RESEARCH, 2008, 14 (02) :396-404
[2]
BOROWITZ MJ, 1993, BLOOD, V82, P1086
[3]
B-CELL PRECURSORS IN NORMAL PEDIATRIC BONE-MARROW [J].
CALDWELL, CW ;
POJE, E ;
HELIKSON, MA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 95 (06) :816-823
[4]
Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy [J].
DaneshManesh, Amir H. ;
Mikaelsson, Eva ;
Jeddi-Tehrani, Mahmood ;
Bayat, Ali Ahmad ;
Ghods, Roya ;
Ostadkarampour, Mahyar ;
Akhondi, Mehdi ;
Lagercrantz, Svetlana ;
Larsson, Catharina ;
Osterborg, Anders ;
Shokri, Fazel ;
Mellstedt, Hakan ;
Rabbani, Hodjattallah .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (05) :1190-1195
[5]
DAVIS RE, 1994, AM J CLIN PATHOL, V102, P202
[6]
Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal,antigen and receptor for Wnt5a [J].
Fukuda, Tetsuya ;
Chen, Liguang ;
Endo, Tomoyuki ;
Tang, Li ;
Lu, Desheng ;
Castro, Jariuario E. ;
Widhopf, George F., II ;
Rassenti, Laura Z. ;
Cantwell, Mark J. ;
Prussak, Charles E. ;
Carson, Dennis A. ;
Kipps, Thomas J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (08) :3047-3052
[7]
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor [J].
Hudecek, Michael ;
Schmitt, Thomas M. ;
Baskar, Sivasubramanian ;
Lupo-Stanghellini, Maria Teresa ;
Nishida, Tetsuya ;
Yamamoto, Tori N. ;
Bleakley, Marie ;
Turtle, Cameron J. ;
Chang, Wen-Chung ;
Greisman, Harvey A. ;
Wood, Brent ;
Maloney, David G. ;
Jensen, Michael C. ;
Rader, Christoph ;
Riddell, Stanley R. .
BLOOD, 2010, 116 (22) :4532-4541
[8]
Flow cytometric analysis of normal B cell differentiation:: a frame of reference for the detection of minimal residual disease in precursor-B-ALL [J].
Lúcio, P ;
Parreira, A ;
van den Beemd, MWM ;
van Lochem, EG ;
van Wering, ER ;
Baars, E ;
Porwit-MacDonald, A ;
Bjorklund, E ;
Gaipa, G ;
Biondi, A ;
Orfao, A ;
Janossy, G ;
van Dongen, JJM ;
San Miguel, JF .
LEUKEMIA, 1999, 13 (03) :419-427
[9]
Contrasting responses of lymphoid progenitors to canonical and noncanonical Wnt signals [J].
Malhotra, Sachin ;
Baba, Yoshihiro ;
Garrett, Karla P. ;
Staal, Frank J. T. ;
Gerstein, Rachel ;
Kincade, Paul W. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (06) :3955-3964
[10]
MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181